Kuo M S, Bock M G, Freidinger R M, Guidotti M T, Lis E V, Pawluczyk J M, Perlow D S, Pettibone D J, Quigley A G, Reiss D R, Williams P D, Woyden C J
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA.
Bioorg Med Chem Lett. 1998 Nov 3;8(21):3081-6. doi: 10.1016/S0960-894X(98)00568-X.
Structure-activity studies on the oxytocin antagonist 1 (L-371,257) have identified a new series of high affinity, receptor-selective OT antagonists in which the N-acetyl-4-piperidinyl ether terminus in 1 has been replaced with a 1-(aryl)ethoxy group.
对催产素拮抗剂1(L-371,257)的构效关系研究已确定了一系列新的高亲和力、受体选择性的催产素拮抗剂,其中1中的N-乙酰基-4-哌啶基醚末端已被1-(芳基)乙氧基取代。